JPRN-jRCTs051190013已完成4 期
Effect of iron containing phosphate binder on iron metabolism of patients undergoing maintenance hemodialysis. - ICBP study
Kuragano Takahiro0 个研究点目标入组 64 人开始时间: 2019年5月9日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
The results suggested that the avoid aimlessly administration of iron containing phosphate binder could maintain target P, Ca, and PTH levels without iron overload and Hb overshot.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Maintenance hemodialysis patient with high serum phosphate level.
排除标准
- •1) Patients who received maintenance hemodialysis for < 6month.
- •2) Patients with severe heart failure (>NYHA III), respiratory failure, malignancy disease, or severe liver dysfunction.
- •3) Patient with high serum ferritin level(>100 ng/mL) at the start of this study.
研究者
相似试验
未知
不适用
Effect of iron containing phosphate binder on iron metabolism of patients undergoing maintenance hemodialysis.Chronic kidney diseaseJPRN-UMIN000023700Hyogo College of Medicine300
已完成
不适用
Efficacy of the iron-based phosphate binder in patients on peritoneal dialysis.chronic renal failureJPRN-UMIN000034472Saiseikai Yokohamashi Tobu Hospital100
已完成
不适用
Effect of iron-contained phosphate binder on serum FGF23 in hemodialysis patients.Chronic renal failureJPRN-UMIN000013972Ojiya general hospital30
已完成
不适用
Efficacy and safety of phosphate binders, ferric citrete hydrate and lanthunam carbohydrate, in patients undergoing maintenance hemodialysisJPRN-UMIN000021818Divisions of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine60
招募中
不适用
Calcium-phosphate Complications Induced by IV Iron Supplementation in Patients With Rendu-Osler DiseaseRendu Osler DiseaseNCT05544669University Hospital, Strasbourg, France220